Spectrum Pharmaceuticals, Inc. (SPPI)
-NasdaqGS 8.36 
0.19(2.22%) 1:20PM EDT - Nasdaq Real Time Price
| Prev Close: | 8.55 |
|---|
| Open: | 8.52 |
|---|
| Bid: | 8.35 x 1000 |
|---|
| Ask: | 8.36 x 200 |
|---|
| 1y Target Est: | 11.38 |
|---|
| Beta: | 1.9 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | 8.34 - 8.58 |
|---|
| 52wk Range: | 6.92 - 17.48 |
|---|
| Volume: | 315,235 |
|---|
| Avg Vol (3m): | 1,466,820 |
|---|
| Market Cap: | 494.75M |
|---|
| P/E (ttm): | 11.70 |
|---|
| EPS (ttm): | 0.71 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Biotech Stock Mailbag: Amarin, MannKind, Palatinat TheStreet(Fri 7:00AM EDT)
- Spectrum Pharmaceuticals to Present Corporate Update at the Deutsche Bank 38th Annual Health Care Conference in Boston on May 30thBusiness Wire(Thu, May 23)
- SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD DisclosureEDGAR Online(Mon, May 20)
- Spectrum Pharmaceuticals' CEO Presents at UBS Global Healthcare Conference (Transcript)at Seeking Alpha(Mon, May 20)
- Outlook for the Most Shorted Stocksat Motley Fool(Fri, May 17)
- SPECTRUM PHARMACEUTICALS INC FinancialsEDGAR Online Financials(Fri, May 17)
- Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharmaat TheStreet(Fri, May 17)
- The 5 Dumbest Things on Wall Street This Week: May 17at TheStreet(Fri, May 17)
- [video] 5 Dumbest Things on Wall Streetat TheStreet(Fri, May 17)
- Spectrum Pharmaceuticals' CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)at Seeking Alpha(Tue, May 14)
- Spectrum Pharma Reports 1Q LossZacks(Tue, May 14)
- 4 Obscure Healthcare Stocks To Watch In 2013at Seeking Alpha(Mon, May 13)
- SEC Is Investigating Spectrum Pharmaat TheStreet(Mon, May 13)
- Spectrum Pharmaceuticals to Present Corporate Update at the UBS Global Healthcare Conference in New York City on May 20thBusiness Wire(Mon, May 13)
- 3 Investment Strategy Lessons From Vertex's Successat Motley Fool(Sat, May 11)
Key Statistics
| Forward P/E (1 yr): | 49.15 |
|---|
| P/S (ttm): | 2.05 |
|---|
| Ex-Dividend Date: | 18-Dec-12 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.17 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.12 |
|---|
| Mean Recommendation*: | 2.8 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Spectrum Pharmaceuticals, Inc., a biotechnology company, engages in acquiring, developing, and commercializing prescription drug products primarily in the areas of hematology and oncology.
View More